{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:41:53Z","timestamp":1785526913048,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000028","name":"Institute of Circulatory and Respiratory Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000028","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51196-5","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:25:55Z","timestamp":1779513955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influenza A\/PR8 virus infection in mice suppresses basal and Oncostatin M-induced IL-33 expression in vivo and in vitro"],"prefix":"10.1038","volume":"16","author":[{"given":"Leila","family":"Somani-Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Buder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0081-2231","authenticated-orcid":false,"given":"Carl D.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"51196_CR1","doi-asserted-by":"crossref","unstructured":"Mulcahy, M. E. & McLoughlin, R. M. Staphylococcus aureus and Influenza A Virus: Partners in Coinfection. mBio 7, (2016).","DOI":"10.1128\/mBio.02068-16"},{"key":"51196_CR2","doi-asserted-by":"publisher","unstructured":"McCullers, J. A. Insights into the interaction between influenza virus and pneumococcus. Clinical Microbiology Reviews vol. 19 571\u2013582 Preprint at (2006). https:\/\/doi.org\/10.1128\/CMR.00058-05","DOI":"10.1128\/CMR.00058-05"},{"key":"51196_CR3","unstructured":"Influenza (seasonal). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"51196_CR4","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S0264-410X(00)00275-9","volume":"19","author":"I Julkunen","year":"2000","unstructured":"Julkunen, I. et al. Inflammatory responses in influenza A virus infection. Vaccine 19, S32\u2013S37 (2000).","journal-title":"Vaccine"},{"key":"51196_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.ajpath.2013.06.023","volume":"183","author":"R Gao","year":"2013","unstructured":"Gao, R. et al. Cytokine and Chemokine Profiles in Lung Tissues from Fatal Cases of 2009 Pandemic Influenza A (H1N1): Role of the Host Immune Response in Pathogenesis. Am. J. Pathol. 183, 1258\u20131268 (2013).","journal-title":"Am. J. Pathol."},{"key":"51196_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","volume":"12","author":"MD De Jong","year":"2006","unstructured":"De Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203 (2006).","journal-title":"Nat. Med."},{"key":"51196_CR7","doi-asserted-by":"publisher","unstructured":"Sichelstiel, A. et al. Targeting IL-1\u03b2 and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation. PLoS One 9, e98440.   PMID: 24918427.  PMCID: PMC4053370.  https:\/\/doi.org\/10.1371\/journal.pone.0098440 (2014).","DOI":"10.1371\/journal.pone.0098440"},{"key":"51196_CR8","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1128\/JVI.79.10.6441-6448.2005","volume":"79","author":"N Schmitz","year":"2005","unstructured":"Schmitz, N., Kurrer, M., Bachmann, M. F. & Kopf, M. Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection. J. Virol. 79, 6441\u20136448 (2005).","journal-title":"J. Virol."},{"key":"51196_CR9","doi-asserted-by":"publisher","unstructured":"Paquette, S. G. et al. Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection. PLoS One 7, e38214.  PMID: 22679491  PMCID: PMC3367995  https:\/\/doi.org\/10.1371\/journal.pone.0038214 (2012).","DOI":"10.1371\/journal.pone.0038214"},{"key":"51196_CR10","doi-asserted-by":"publisher","unstructured":"Yang, M. L. et al. IL-6 ameliorates acute lung injury in influenza virus infection. Sci Rep 7, 43829    PMID: 28262742  PMCID: PMC5338329 https:\/\/doi.org\/10.1038\/srep43829 (2017).","DOI":"10.1038\/srep43829"},{"key":"51196_CR11","doi-asserted-by":"publisher","unstructured":"Zhang, J. et al. Interleukin-6 and granulocyte colony-stimulating factor as predictors of the prognosis of influenza-associated pneumonia. BMC Infect. Dis 22, 343 PMCID: PMC8983324  PMID: 35382755.  https:\/\/doi.org\/10.1186\/s12879-022-07321-6 (2022).","DOI":"10.1186\/s12879-022-07321-6"},{"key":"51196_CR12","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1016\/j.ajpath.2011.09.003","volume":"179","author":"D Damjanovic","year":"2011","unstructured":"Damjanovic, D. et al. Negative regulation of lung inflammation and immunopathology by TNF-\u03b1 during acute influenza infection. Am. J. Pathol. 179, 2963\u20132976 (2011).","journal-title":"Am. J. Pathol."},{"key":"51196_CR13","doi-asserted-by":"crossref","unstructured":"Martin, N. T. & Martin, M. U. Interleukin 33 is a guardian of barriers and a local alarmin. Nature Immunology 2016 17:2 17, 122\u2013131 (2016).","DOI":"10.1038\/ni.3370"},{"key":"51196_CR14","doi-asserted-by":"publisher","first-page":"155891","DOI":"10.1016\/j.cyto.2022.155891","volume":"156","author":"C Cayrol","year":"2022","unstructured":"Cayrol, C. & Girard, J. P. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine 156, 155891 (2022).","journal-title":"Cytokine"},{"key":"51196_CR15","doi-asserted-by":"crossref","unstructured":"Liew, F. Y., Girard, J. P. & Turnquist, H. R. Interleukin-33 in health and disease. Nature Reviews Immunology 2016 16:11 16, 676\u2013689 (2016).","DOI":"10.1038\/nri.2016.95"},{"key":"51196_CR16","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1002\/eji.200940026","volume":"39","author":"HR Turnquist","year":"2009","unstructured":"Turnquist, H. R. & Thomson, A. W. IL-33 broadens its repertoire to affect DC. Eur. J. Immunol. 39, 3292\u20133295 (2009).","journal-title":"Eur. J. Immunol."},{"key":"51196_CR17","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1002\/eji.201141629","volume":"41","author":"Q Yang","year":"2011","unstructured":"Yang, Q. et al. IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8\u2009+\u2009T cells. Eur. J. Immunol. 41, 3351\u20133360 (2011).","journal-title":"Eur. J. Immunol."},{"key":"51196_CR18","first-page":"984","volume":"335","author":"WV Bonilla","year":"2012","unstructured":"Bonilla, W. V. et al. The alarmin interleukin-33 drives protective antiviral CD8\u2009+\u2009T cell responses. Sci. (1979). 335, 984\u2013989 (2012).","journal-title":"Sci. (1979)"},{"key":"51196_CR19","doi-asserted-by":"publisher","unstructured":"Gu, S. et al. The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases. Frontiers in Immunology vol. 15 Preprint at (2024). https:\/\/doi.org\/10.3389\/fimmu.2024.1436437","DOI":"10.3389\/fimmu.2024.1436437"},{"key":"51196_CR20","doi-asserted-by":"publisher","unstructured":"Weinberg, E. O. et al. IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages. PLoS One 14, e0210827.  https:\/\/doi.org\/10.1371\/journal.pone.0210827 (2019).","DOI":"10.1371\/journal.pone.0210827"},{"key":"51196_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1189\/jlb.0811425","volume":"91","author":"D Talabot-Ayer","year":"2011","unstructured":"Talabot-Ayer, D. et al. The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters. J. Leukoc. Biol. 91, 119\u2013125 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"51196_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1165\/rcmb.2010-0516OC","volume":"45","author":"R Le Goffic","year":"2011","unstructured":"Le Goffic, R. et al. Infection with influenza virus induces IL-33 in murine lungs. Am. J. Respir Cell. Mol. Biol. 45, 1125\u20131132 (2011).","journal-title":"Am. J. Respir Cell. Mol. Biol."},{"key":"51196_CR23","unstructured":"Bian, J. R. et al. Clinical Aspects and Cytokine Response in Adults with Seasonal Influenza Infection. Int J Clin Exp Med vol. 7 www.ijcem.com\/ (2014)."},{"key":"51196_CR24","doi-asserted-by":"crossref","unstructured":"Kim, C. W., Yoo, H. J., Park, J. H., Oh, J. E. & Lee, H. K. Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection. Viruses 11, (2019).","DOI":"10.3390\/v11090840"},{"key":"51196_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/mi.2017.32","volume":"11","author":"KM Robinson","year":"2018","unstructured":"Robinson, K. M. et al. Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection. Mucosal Immunol. 11, 199\u2013208 (2018).","journal-title":"Mucosal Immunol."},{"key":"51196_CR26","doi-asserted-by":"crossref","unstructured":"Richards, C. D. The Enigmatic Cytokine Oncostatin M and Roles in Disease. ISRN Inflamm. 2013, 1\u201323 (2013).","DOI":"10.1155\/2013\/512103"},{"key":"51196_CR27","doi-asserted-by":"publisher","first-page":"e12694","DOI":"10.1111\/sji.12694","volume":"88","author":"NR West","year":"2018","unstructured":"West, N. R., Owens, B. M. J. & Hegazy, A. N. The oncostatin M-stromal cell axis in health and disease. Scand. J. Immunol. 88, e12694 (2018).","journal-title":"Scand. J. Immunol."},{"key":"51196_CR28","first-page":"169","volume":"389","author":"DA Hoagland","year":"2025","unstructured":"Hoagland, D. A. et al. Macrophage-derived oncostatin M repairs the lung epithelial barrier during inflammatory damage. Sci. (1979). 389, 169\u2013175 (2025).","journal-title":"Sci. (1979)"},{"key":"51196_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4049\/jimmunol.0903476","volume":"186","author":"DK Fritz","year":"2011","unstructured":"Fritz, D. K. et al. A Mouse Model of Airway Disease: Oncostatin M-Induced Pulmonary Eosinophilia, Goblet Cell Hyperplasia, and Airway Hyperresponsiveness Are STAT6 Dependent, and Interstitial Pulmonary Fibrosis Is STAT6 Independent. J. Immunol. 186, 1107\u20131118 (2011).","journal-title":"J. Immunol."},{"key":"51196_CR30","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/labinvest.2014.81","volume":"94","author":"S Wong","year":"2014","unstructured":"Wong, S., Botelho, F. M., Rodrigues, R. M. & Richards, C. D. Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 dysregulation in lungs of fibrosis-resistant BALB\/c mice. Lab. Invest. 94, 1003\u20131016 (2014).","journal-title":"Lab. Invest."},{"key":"51196_CR31","doi-asserted-by":"crossref","unstructured":"Botelho, F. et al. IL-33 Mediates Lung Inflammation by the IL-6-Type Cytokine Oncostatin M. Mediators Inflamm. 2020, (2020).","DOI":"10.1155\/2020\/4087315"},{"key":"51196_CR32","doi-asserted-by":"crossref","unstructured":"Richards, C. D. et al. Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells. Mediators Inflamm. 2016, (2016).","DOI":"10.1155\/2016\/9858374"},{"key":"51196_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/imcb.1035","volume":"96","author":"A Dubey","year":"2018","unstructured":"Dubey, A. et al. Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo. Immunol. Cell. Biol. 96, 257\u2013272 (2018).","journal-title":"Immunol. Cell. Biol."},{"key":"51196_CR34","doi-asserted-by":"publisher","unstructured":"Wu, W. & Metcalf, J. P. The Role of Type i IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains? Journal of Innate Immunity vol. 12 437\u2013447 Preprint at (2020). https:\/\/doi.org\/10.1159\/000508379","DOI":"10.1159\/000508379"},{"key":"51196_CR35","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Sastre, A. Induction and evasion of type I interferon responses by influenza viruses. Virus Research vol. 162 12\u201318 Preprint at (2011). https:\/\/doi.org\/10.1016\/j.virusres.2011.10.017","DOI":"10.1016\/j.virusres.2011.10.017"},{"key":"51196_CR36","doi-asserted-by":"publisher","first-page":"17481","DOI":"10.1038\/s41598-023-44797-x","volume":"13","author":"A Rojas-Ruiz","year":"2023","unstructured":"Rojas-Ruiz, A. et al. Lung stiffness of C57BL\/6 versus BALB\/c mice. Sci. Rep. |. 13, 17481 (2023).","journal-title":"Sci. Rep. |"},{"key":"51196_CR37","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.1115884109","volume":"109","author":"E Lefran\u00e7ais","year":"2012","unstructured":"Lefran\u00e7ais, E. et al. IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc. Natl. Acad. Sci. U S A. 109, 1673\u20131678 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"51196_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","volume":"31","author":"AU L\u00fcthi","year":"2009","unstructured":"L\u00fcthi, A. U. et al. Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases. Immunity 31, 84\u201398 (2009).","journal-title":"Immunity"},{"key":"51196_CR39","doi-asserted-by":"publisher","unstructured":"Hiemstra, P. S. & Heijink, I. H. Oxidation alters IL-33 function: new insights in the biology of different forms of IL-33 and their relevance for COPD. European Respiratory Journal vol. 62 Preprint at (2023). https:\/\/doi.org\/10.1183\/13993003.01301-2023","DOI":"10.1183\/13993003.01301-2023"},{"key":"51196_CR40","doi-asserted-by":"publisher","unstructured":"Strickson, S. et al. Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex. European Respiratory Journal 62(3), 2202210,  PMID: 37442582 PMCID: PMC10533947  https:\/\/doi.org\/10.1183\/13993003.02210-2022DOI:10.1183\/13993003.02210-2022 (2023).","DOI":"10.1183\/13993003.02210-2022"},{"key":"51196_CR41","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.4049\/jimmunol.170.9.4601","volume":"170","author":"G Wohlleben","year":"2003","unstructured":"Wohlleben, G. et al. Influenza A Virus Infection Inhibits the Efficient Recruitment of Th2 Cells into the Airways and the Development of Airway Eosinophilia. J. Immunol. 170, 4601\u20134611 (2003).","journal-title":"J. Immunol."},{"key":"51196_CR42","doi-asserted-by":"publisher","first-page":"34843491","DOI":"10.4049\/jimmunol.165.6.3484","volume":"165","author":"DC Tsitoura","year":"2000","unstructured":"Tsitoura, D. C. et al. Respiratory Infection with Influenza A Virus Interferes with the Induction of Tolerance to Aeroallergens1. J. Immunol. 165, 34843491 (2000).","journal-title":"J. Immunol."},{"key":"51196_CR43","doi-asserted-by":"publisher","unstructured":"Matsukura, S. et al. Differential regulation of eotaxin expression by IFN-\u03b3 in airway epithelial cells. (2003). https:\/\/doi.org\/10.1067\/mai.2003.1513.","DOI":"10.1067\/mai.2003.1513"},{"key":"51196_CR44","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.jaci.2012.01.052","volume":"129","author":"M Crapster-Pregont","year":"2012","unstructured":"Crapster-Pregont, M., Yeo, J., Sanchez, R. L. & Kuperman, D. A. Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production. J. Allergy Clin. Immunol. 129, 1621\u20131627e3 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"51196_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/labinvest.2008.82","volume":"88","author":"M Suzukawa","year":"2008","unstructured":"Suzukawa, M. et al. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab. Invest. 88, 1245\u20131253 (2008).","journal-title":"Lab. Invest."},{"key":"51196_CR46","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.4049\/jimmunol.1600787","volume":"198","author":"AE Samarasinghe","year":"2017","unstructured":"Samarasinghe, A. E. et al. Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus. J. Immunol. 198, 3214\u20133226 (2017).","journal-title":"J. Immunol."},{"key":"51196_CR47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1128\/mr.44.2.303-330.1980","volume":"44","author":"C Sweet","year":"1980","unstructured":"Sweet, C. & Smith, H. Pathogenicity of influenza virus. Microbiol. Rev. 44, 303\u2013330 (1980).","journal-title":"Microbiol. Rev."},{"key":"51196_CR48","doi-asserted-by":"publisher","unstructured":"George, S. T. et al. Neutrophils and Influenza: A Thin Line between Helpful and Harmful. Vaccines (Basel) 597,  PMID: 34199803. PMCID: PMC8228962  https:\/\/doi.org\/10.3390\/vaccines9060597 (2021).","DOI":"10.3390\/vaccines9060597"},{"key":"51196_CR49","doi-asserted-by":"publisher","first-page":"e17618","DOI":"10.1371\/journal.pone.0017618","volume":"6","author":"MD Tate","year":"2011","unstructured":"Tate, M. D. et al. The Role of Neutrophils during Mild and Severe Influenza Virus Infections of Mice. PLoS One. 6, e17618 (2011).","journal-title":"PLoS One"},{"key":"51196_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41385-018-0115-3","volume":"12","author":"U Kulkarni","year":"2019","unstructured":"Kulkarni, U. et al. Excessive neutrophil levels in the lung underlie the age-associated increase in influenza mortality. Mucosal Immunol. 12, 545\u2013554 (2019).","journal-title":"Mucosal Immunol."},{"key":"51196_CR51","first-page":"3109","volume":"18","author":"M Jiang","year":"2019","unstructured":"Jiang, M. et al. Type 2 innate lymphoid cells participate in IL-33-stimulated Th2-associated immune response in chronic obstructive pulmonary disease. Exp. Ther. Med. 18, 3109\u20133116 (2019).","journal-title":"Exp. Ther. Med."},{"key":"51196_CR52","doi-asserted-by":"publisher","first-page":"e0173008","DOI":"10.1371\/journal.pone.0173008","volume":"12","author":"A Kawaguchi","year":"2017","unstructured":"Kawaguchi, A. et al. Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection. PLoS One. 12, e0173008 (2017).","journal-title":"PLoS One"},{"key":"51196_CR53","doi-asserted-by":"publisher","unstructured":"Kopach, P. et al. IFN-Directly Controls IL-33 Protein Level through a STAT1-and LMP2-dependent Mechanism *. (2014). https:\/\/doi.org\/10.1074\/jbc.M113.534396.","DOI":"10.1074\/jbc.M113.534396"},{"key":"51196_CR54","doi-asserted-by":"crossref","unstructured":"Duerr, C. U. et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nature Immunology 2015 17:1 17, 65\u201375 (2015).","DOI":"10.1038\/ni.3308"},{"key":"51196_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/23120541.00147-2020","volume":"6","author":"S Ramu","year":"2020","unstructured":"Ramu, S. et al. TLR3\/TAK1 signalling regulates rhinovirus-induced interleukin-33 in bronchial smooth muscle cells. ERJ Open. Res. 6, 1\u201310 (2020).","journal-title":"ERJ Open. Res."},{"key":"51196_CR56","doi-asserted-by":"publisher","unstructured":"Farias, R. & Rousseau, S. The TAK1\u2192IKK\u03b2\u2192TPL2\u2192MKK1\/MKK2 signaling cascade regulates IL-33 expression in cystic fibrosis airway epithelial cells following infection by Pseudomonas aeruginosa. Front Cell. Dev. Biol 3, 87.  PMCID: PMC4707240  PMID: 26793709  https:\/\/doi.org\/10.3389\/fcell.2015.00087  (2016).","DOI":"10.3389\/fcell.2015.00087"},{"key":"51196_CR57","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S1097-2765(00)80099-4","volume":"1","author":"ME Nemeroff","year":"1998","unstructured":"Nemeroff, M. E., Barabino, S. M. L., Li, Y., Keller, W. & Krug, R. M. Influenza virus NS1 protein interacts with the cellular 30\u00a0kDa subunit of CPSF and inhibits 3\u2032 end formation of cellular pre-mRNAs. Mol. Cell. 1, 991\u20131000 (1998).","journal-title":"Mol. Cell."},{"key":"51196_CR58","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/emboj\/18.8.2273","volume":"18","author":"Z Chen","year":"1999","unstructured":"Chen, Z., Li, Y., Krug, R. M. & Influenza A virus NS1 protein targetspoly(A)-binding protein II of the cellular 3\u2032\u2010end processing machinery. EMBO J. 18, 2273\u20132283 (1999).","journal-title":"EMBO J."},{"key":"51196_CR59","doi-asserted-by":"publisher","unstructured":"Tisoncik, J. R. et al. The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways. https:\/\/doi.org\/10.1099\/vir.0.032060-0.","DOI":"10.1099\/vir.0.032060-0"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51196-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:06:01Z","timestamp":1785521161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51196-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51196"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51196-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23574"}}